Jennifer Buell

Insider Reports History

Entity
Individual
Location
3 Forbes Road, Lexington, MA
Signature
Christine M. Klaskin, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jennifer Buell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MiNK Therapeutics, Inc. Chief Executive Officer Common Stock 232K $241K $1.04 Oct 11, 2023 Direct
AGENUS INC Chairman Executive Council, Director Common Stock 13.7K $211K $15.46 Jun 11, 2024 Direct
Protagenic Therapeutics, Inc.\new Director PTIX Common stock Options 75K $131K $1.74 Mar 25, 2024 Direct
MiNK Therapeutics, Inc. Chief Executive Officer Stock Option 661K Jan 16, 2024 Direct
MiNK Therapeutics, Inc. Chief Executive Officer Restricted Stock Units 0 Oct 11, 2023 Direct

Insider Reports Filed by Jennifer Buell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AGEN AGENUS INC Jun 11, 2024 0 $0 3 Jun 20, 2024 Chairman Executive Council, Director
PTIX Protagenic Therapeutics, Inc.\new Mar 25, 2024 1 $131K 4 Mar 29, 2024 Director
INKT MiNK Therapeutics, Inc. Jan 18, 2024 2 $0 4 Jan 18, 2024 Chief Executive Officer
INKT MiNK Therapeutics, Inc. Oct 11, 2023 2 $0 4 Oct 13, 2023 Chief Executive Officer, Director
INKT MiNK Therapeutics, Inc. Sep 29, 2023 3 -$151K 4 Oct 3, 2023 Chief Executive Officer, Director
INKT MiNK Therapeutics, Inc. Sep 27, 2023 2 $0 4 Sep 29, 2023 Chief Executive Officer
INKT MiNK Therapeutics, Inc. Jan 9, 2023 2 $399K 4 Jan 11, 2023 Chief Executive Officer
INKT MiNK Therapeutics, Inc. Jan 21, 2022 1 $0 4 Jan 25, 2022 President, Chief Executive Officer, Director
INKT MiNK Therapeutics, Inc. Oct 13, 2021 0 $0 3 Oct 20, 2021 President, Chief Executive Officer Exhibit List: Exhibit 24 - Power of Attorney, Director
AGEN AGENUS INC Jun 15, 2021 2 $58.2K 4 Jul 2, 2021 COO and President